PPAR gamma agonists (Dr Reddy's/Pulmagen)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePPAR gamma agonists (Dr Reddy's/Pulmagen)
Drug Alias NamePPAR gamma agonists (Argenta/Dr Reddy's)anti-inflammatories (Argenta/Dr Reddy's)ADC-3277PHT-46ADC-3322 +[8] 
ClassificationSmall molecules
Mechanisms of ActionPeroxisome proliferator-activated receptor γ agonistsInsulin sensitizers
TargetsPeroxisome proliferator-activated receptor γ
Therapy Area/IndicationsDiabetes Mellitus, Type 2Pulmonary Disease, Chronic ObstructiveAsthma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomIndia
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDr.Reddy's Laboratories Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPulmagen TherapeuticsArgenta DiscoveryDr.Reddy's Laboratories Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Pulmonary Disease, Chronic ObstructiveAsthma +[4] 

Other Information

ATC CodeN/A
Related LinksN/A